Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 13 March 2023, 16:35 HKT/SGT
Share:
    

Source: China Tonghai Securities Limited
Tonghai Securities Obtains Approval from SFC, Becomes One of the Pioneers to Provide Virtual Asset Related Services in Hong Kong

HONG KONG, Mar 13, 2023 - (ACN Newswire) - China Tonghai International Financial Limited (Stock Code: 00952.HK) is pleased to announce that its wholly owned subsidiary China Tonghai Securities Limited ("Tonghai Securities" or "the Company") is now one of the first full-fledged brokerage firms in Hong Kong to provide virtual asset ("VA") dealing and advisory services to the professional investors.

Tonghai Securities has been licensed by the Securities and Futures Commission (SFC) to conduct Type 1 (dealing in securities), Type 4 (advising on securities) and Type 9 (asset management) regulated activities. Pursuant to the regulatory approach outlined in "SFC-HKMA Joint Circular on Intermediaries' Virtual Asset-related Activities", the Company has successfully obtained the SFC's approval for expansion of its business scope to cover (i)distribution of VA-related products; (ii)provision of VA dealing services; and (iii)provision of VA advisory services, subject to additional licensing conditions. .

Mr. Calvin Chiu, Deputy Chief Executive Officer of Tonghai Securities says, "In recent years, VA have been undergoing rapid development. Effectivesupervision is essential to promote investor confidence as well as to support a healthy and long-term development of the industry. The newly approved business scope marks the refreshing beginning of our business. We will take advantage of the new services to expand our presence in the market. In addition to that, we are more focused than ever in our commitment to protect interests of clients by providing safe and reliable services in the VA market."

About China Tonghai International Financial Limited
China Tonghai International Financial Limited (the "Company", Stock Code: 00952.HK) is a Hong Kong based financial services group which is listed on the Main Board of the Stock Exchange of Hong Kong Limited. The Company was publicly listed in Hong Kong in 1997, it is committed to building a comprehensive, full-licensed integrated financial platform. The core businesses of the Company are brokerage business, interest income business, corporate finance business, asset management business and investments and others businesses. The Company strives to become the ideal partner for both corporate and individual investors in Hong Kong and China. The Company also offers premier one-stop financial services to its clients.

For further information, please contact:
Quam IR Limited
Mandy Lo Tel: (852) 2217-2753 Email: mandy.lo@tonghaifinancial.com
Charlie Chan Tel: (852) 2217-2504 Email: charlie.chan@tonghaifinancial.com



Topic: Press release summary
Source: China Tonghai Securities Limited

Sectors: Daily Finance
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Spritzer Scores Big with 'Meet the Red Legends' Event for Football Fans  
Apr 28, 2024 18:00 HKT/SGT
Announcing Mad About Marketing - A New Member of the Digital Sukoon Private Limited Family  
Apr 28, 2024 17:00 HKT/SGT
HKTDC unveils gifts, printing, packaging and licensing events  
Apr 27, 2024 20:00 HKT/SGT
Masverse Unveils Groundbreaking Blockchain Platform  
Apr 27, 2024 02:40 HKT/SGT
FinTech Funding Continues to Surge as Second Edition of Dubai FinTech Summit Commences  
Apr 26, 2024 21:10 HKT/SGT
TIME Interconnect Technology Limited Announces Final Results For The Nine Months Ended 31 December 2023  
Apr 26, 2024 18:26 HKT/SGT
UK advertising reports GBP36.6bn spend in 2023  
Apr 26, 2024 17:30 HKT/SGT
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine  
Apr 26, 2024 15:36 HKT/SGT
Edvantage Group Announces FY2024 Interim Results  
Apr 26, 2024 13:43 HKT/SGT
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project  
Apr 26, 2024 13:27 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: